000 01478 a2200373 4500
005 20250514023307.0
264 0 _c20020712
008 200207s 0 0 eng d
022 _a1053-8569
024 7 _a10.1002/pds.634
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aValuck, R J
245 0 0 _aCo-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers.
_h[electronic resource]
260 _bPharmacoepidemiology and drug safety
_c
300 _a511-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Topical
650 0 4 _aAdrenergic beta-Antagonists
_xadministration & dosage
650 0 4 _aDepressive Disorder
_xcomplications
650 0 4 _aDrug Prescriptions
650 0 4 _aGlaucoma
_xcomplications
650 0 4 _aHeart Failure
_xcomplications
650 0 4 _aHospitals, Veterans
650 0 4 _aHumans
650 0 4 _aInformation Systems
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xcomplications
650 0 4 _aVeterans
700 1 _aPerlman, J I
700 1 _aAnderson, C
700 1 _aWortman, G I
773 0 _tPharmacoepidemiology and drug safety
_gvol. 10
_gno. 6
_gp. 511-6
856 4 0 _uhttps://doi.org/10.1002/pds.634
_zAvailable from publisher's website
999 _c11738283
_d11738283